Drawing for MEDENDI BEST CARE IN MEDICAL CARE

USPTO serial 79372923

MEDENDI BEST CARE IN MEDICAL CARE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BECHHOFER, YOCHEVED D
Law office
TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with MEDENDI BEST CARE IN MEDICAL CARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
042Medical and pharmacological research services; medical research; scientific investigations for medical purposes; medical research in the field of oncology; scientific research for medical purposes in the area of cancerous diseasesACTIVE—
044Medical services; genetic testing for medical purposes; medical assistance consultancy provided by doctors and other specialized medical personnel; DNA screening for medical purposes; services for the testing of blood; blood bank services; human tissue bank services; analysis of human tissues for medical treatment; telemedicine services; physiotherapy; speech therapy; therapy services; voice and speech therapy services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical laboratory services for the analysis of blood samples taken from patients; X-ray services; medical diagnostic services; medical analysis services for cancer diagnosis and prognosis; RNA or DNA analysis for cancer diagnosis and prognosis; medical clinic servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jul 25, 2024MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 25, 2024ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 31, 2024RFNTREFUSAL PROCESSED BY IB—
Jan 9, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 9, 2024RFRRREFUSAL PROCESSED BY MPU—
Dec 27, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 26, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 22, 2023DOCKASSIGNED TO EXAMINER—
Jul 7, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 3, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 29, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance